Some patients may transition to physician-supervised semaglutide after an individualized evaluation
Some patients take them long-term for maintenance, while others taper off under medical guidance after achieving goals
When the gut barrier is already under assault from a pathogen, Akkermansia activity can worsen the situation rather than improve it
Even as Wegovy, Mounjaro, and other GLP-1 therapies become household names on par with Tylenol and Kleenex, financially burdened payers and employers are beginning to restrict coverage and drop the drugs from their formularies
In a head-to-head trial published in the New England Journal of Medicine in May 2025, Mounjaro users lost 20.2 percent of body weight compared to 13.7 percent for Wegovy users
Mice were challenged after 21 days by intradermal immunization in the base of the tail with this emulsion